BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17464267)

  • 1. Somatostatin receptor PET imaging with Gallium-68 labeled peptides.
    Win Z; Al-Nahhas A; Rubello D; Gross MD
    Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):244-50. PubMed ID: 17464267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gallium-68 PET: a new frontier in receptor cancer imaging.
    Al-Nahhas A; Win Z; Szyszko T; Singh A; Nanni C; Fanti S; Rubello D
    Anticancer Res; 2007; 27(6B):4087-94. PubMed ID: 18225576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What can gallium-68 PET add to receptor and molecular imaging?
    Al-Nahhas A; Win Z; Szyszko T; Singh A; Khan S; Rubello D
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):1897-901. PubMed ID: 17713764
    [No Abstract]   [Full Text] [Related]  

  • 4. 68Ga-labelled DOTA-derivatised peptide ligands.
    Meyer GJ; Mäcke H; Schuhmacher J; Knapp WH; Hofmann M
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1097-104. PubMed ID: 15029459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application and Dosimetric Requirements for Gallium-68-labeled Somatostatin Analogues in Targeted Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors.
    Taïeb D; Garrigue P; Bardiès M; Abdullah AE; Pacak K
    PET Clin; 2015 Oct; 10(4):477-86. PubMed ID: 26384594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of gallium-68 labeled somatostatin receptors in PET/CT imaging.
    Ambrosini V; Nanni C; Fanti S
    PET Clin; 2014 Jul; 9(3):323-9. PubMed ID: 25030395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallium-68 in Medical Imaging.
    Martiniova L; Palatis L; Etchebehere E; Ravizzini G
    Curr Radiopharm; 2016; 9(3):187-207. PubMed ID: 27804868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiolabelling DOTA-peptides with 68Ga.
    Breeman WA; de Jong M; de Blois E; Bernard BF; Konijnenberg M; Krenning EP
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):478-85. PubMed ID: 15655678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5.
    Wild D; Mäcke HR; Waser B; Reubi JC; Ginj M; Rasch H; Müller-Brand J; Hofmann M
    Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):724. PubMed ID: 15551131
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiometal-labeled somatostatin analogs for applications in cancer imaging and therapy.
    Lewis JS; Anderson CJ
    Methods Mol Biol; 2007; 386():227-40. PubMed ID: 18604948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of Gallium-68.
    Banerjee SR; Pomper MG
    Appl Radiat Isot; 2013 Jun; 76():2-13. PubMed ID: 23522791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The untapped potential of Gallium 68-PET: the next wave of ⁶⁸Ga-agents.
    Smith DL; Breeman WA; Sims-Mourtada J
    Appl Radiat Isot; 2013 Jun; 76():14-23. PubMed ID: 23232184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).
    Shokeen M; Anderson CJ
    Acc Chem Res; 2009 Jul; 42(7):832-41. PubMed ID: 19530674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (68)Ga-labeled peptides in tumor imaging.
    Maecke HR; Hofmann M; Haberkorn U
    J Nucl Med; 2005 Jan; 46 Suppl 1():172S-8S. PubMed ID: 15653666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography study on pancreatic somatostatin receptors in normal and diabetic rats with 68Ga-DOTA-octreotide: a potential PET tracer for beta cell mass measurement.
    Sako T; Hasegawa K; Nishimura M; Kanayama Y; Wada Y; Hayashinaka E; Cui Y; Kataoka Y; Senda M; Watanabe Y
    Biochem Biophys Res Commun; 2013 Dec; 442(1-2):79-84. PubMed ID: 24220338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-step ¹⁸F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET).
    Wängler C; Waser B; Alke A; Iovkova L; Buchholz HG; Niedermoser S; Jurkschat K; Fottner C; Bartenstein P; Schirrmacher R; Reubi JC; Wester HJ; Wängler B
    Bioconjug Chem; 2010 Dec; 21(12):2289-96. PubMed ID: 21082773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallium-68-DOTA-albumin as a PET blood-pool marker: experimental evaluation in vivo.
    Hoffend J; Mier W; Schuhmacher J; Schmidt K; Dimitrakopoulou-Strauss A; Strauss LG; Eisenhut M; Kinscherf R; Haberkorn U
    Nucl Med Biol; 2005 Apr; 32(3):287-92. PubMed ID: 15820764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals.
    Fani M; André JP; Maecke HR
    Contrast Media Mol Imaging; 2008; 3(2):67-77. PubMed ID: 18383558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automation synthesis modules review.
    Boschi S; Lodi F; Malizia C; Cicoria G; Marengo M
    Appl Radiat Isot; 2013 Jun; 76():38-45. PubMed ID: 23084477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression imaging with radiolabeled peptides.
    Buchsbaum DJ; Chaudhuri TR; Yamamoto M; Zinn KR
    Ann Nucl Med; 2004 Jun; 18(4):275-83. PubMed ID: 15359919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.